The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global virus filtration market was valued at US$ 3.6 Billion in 2021.
We expect the global virus filtration market to exhibit a CAGR of 11.2% during 2022-2027.
The high prevalence of numerous chronic diseases, along with the growing adoption of virus filtration
method in manufacturing of various biotherapeutic products, is primarily catalyzing the global virus
The sudden outbreak of the COVID-19 pandemic has led to the rising application for potential therapies
to treat coronavirus infected patients under critical conditions, thereby increasing the application for
virus filtration in the convalescent plasma for reducing inflammatory mediators.
Based on the product, the global virus filtration market can be segmented into consumables,
instruments, and services. Among these, consumables hold the majority of the total market share.
Based on the application, the global virus filtration market has been divided into biologicals, medical
devices, water purification, air purification, and others. Currently, biologicals exhibit a clear dominance
in the market.
Based on the end use, the global virus filtration market can be categorized into biopharmaceutical and
biotechnology companies, contract research organizations, academic institutes and research
laboratories, and others. Among these, biopharmaceutical and biotechnology companies currently
account for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global virus filtration market include Asahi Kasei Medical Co. Ltd.,
Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG, and
Thermo Fisher Scientific Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at